Pharmaxis Limited (ASX:PXS) has extended its first half net loss by 6 per cent to $20.8 million and declined to pay a dividend. The pharmaceutical company’s first half revenue jumped 77 per cent to almost $6 billion as it shipped its first commercial product Aridol to customers around the world. Shares in Pharmaxis have slipped 2.34 per cent and are trading at $0.63.
The revenue only from Aridol is eye catching $6bn !!!!
Vow this is def. a bargain of the century at current prices with or without Bronchitol!!
DYOR
PXS Price at posting:
61.5¢ Sentiment: Buy Disclosure: Held
